Zhainib was born in San Francisco, California but grew up in a small town outside of Jerusalem before moving back to the Bay Area where she attended San Francisco State University (SFSU). She received her B.S. in Microbiology, and her M.S. in Cell and Molecular Biology from SFSU in the summers of 2016 and 2018, respectively. For her master’s thesis work, she joined the laboratory of Dr. Joseph Chen, whose research focused on nitrogen fixation and microbe-host interactions, using Sinorhizobium meliloti- Medicago truncatula as a model. Zhainib investigated whether the flagella of S. meliloti contribute to biofilm formation during host colonization. She sought a research position in biotechnology after completing her M.S. degree, and in 2018, she became a researcher in the Molecular Biology Department at Genentech Inc. She joined the Haley laboratory which specializes in developing and applying new genome editing technologies for clinical research purposes. She was tasked with optimizing a gene circuit composed of Cas9 and an anti-CRISPR protein, to effectively induce gene deletion in cancer cell lines. Additionally, she is currently supporting the individualized Neoantigen Specific Therapy (iNEST) research program at Genentech by optimizing, and developing mRNA-based personalized cancer vaccines. Zhainib is interested in a range of topics, from cell biology to human diseases, and is excited to join the ChEM-H CBI program where she looks to integrate Chemistry and Biology for an enriched and collaborative research experience and hopes to apply her newfound skills to studying rare human diseases.